BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

940 related articles for article (PubMed ID: 26126706)

  • 1. Combining standard clinical methods with PCR showed improved diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies and prolonged neutropenia.
    Paholcsek M; Fidler G; Konya J; Rejto L; Mehes G; Bukta E; Loeffler J; Biro S
    BMC Infect Dis; 2015 Jul; 15():251. PubMed ID: 26126706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
    Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S; Kuştimur S; Kalkancı A
    Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of serum galactomannan antigen testing combined with chest computed tomography for early diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies with febrile neutropenia after antifungal drug treatment.
    Wang X; Guo G; Cai R; He P; Zhang M
    J Int Med Res; 2019 Feb; 47(2):783-790. PubMed ID: 30477369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients.
    Hsu LY; Ding Y; Phua J; Koh LP; Chan DS; Khoo KL; Tambyah PA
    BMC Infect Dis; 2010 Mar; 10():44. PubMed ID: 20199673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of clinical characteristics on the performance of galactomannan and PCR for the diagnosis of invasive aspergillosis in febrile neutropenic patients.
    Oz Y; Aslan M; Aksit F; Metintas S; Gunduz E
    Mycoses; 2016 Feb; 59(2):86-92. PubMed ID: 26627843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
    Maertens J; Theunissen K; Verhoef G; Verschakelen J; Lagrou K; Verbeken E; Wilmer A; Verhaegen J; Boogaerts M; Van Eldere J
    Clin Infect Dis; 2005 Nov; 41(9):1242-50. PubMed ID: 16206097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics, radiologic findings, risk factors and outcomes of serum galactomannan-negative invasive pulmonary aspergillosis.
    Jung J; Kim MY; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    J Microbiol Immunol Infect; 2018 Dec; 51(6):802-809. PubMed ID: 28712819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignancies.
    Ulusakarya A; Chachaty E; Vantelon JM; Youssef A; Tancrède C; Pico JL; Bourhis JH; Fenaux P; Munck JN
    Hematol J; 2000; 1(2):111-6. PubMed ID: 11920178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
    Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
    Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance.
    Racil Z; Kocmanova I; Toskova M; Buresova L; Weinbergerova B; Lengerova M; Rolencova M; Winterova J; Hrncirova K; Volfova P; Skrickova J; Mayer J
    Int J Infect Dis; 2011 Dec; 15(12):e874-81. PubMed ID: 22040924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients.
    Luong ML; Clancy CJ; Vadnerkar A; Kwak EJ; Silveira FP; Wissel MC; Grantham KJ; Shields RK; Crespo M; Pilewski J; Toyoda Y; Kleiboeker SB; Pakstis D; Reddy SK; Walsh TJ; Nguyen MH
    Clin Infect Dis; 2011 May; 52(10):1218-26. PubMed ID: 21507918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of MycAssay Aspergillus DNA real-time PCR assay compared with the galactomannan detection assay for the diagnosis of invasive aspergillosis from serum samples.
    Danylo A; Courtemanche C; Pelletier R; Boudreault AA
    Med Mycol; 2014 Aug; 52(6):577-83. PubMed ID: 25023484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies.
    Florent M; Katsahian S; Vekhoff A; Levy V; Rio B; Marie JP; Bouvet A; Cornet M
    J Infect Dis; 2006 Mar; 193(5):741-7. PubMed ID: 16453271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of polymerase chain reaction and galactomannan for the diagnosis of invasive aspergillosis in patients with febrile neutropenia.
    Aslan M; Oz Y; Aksit F; Akay OM
    Mycoses; 2015 Jun; 58(6):343-9. PubMed ID: 25851634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
    Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis.
    Francesconi A; Kasai M; Petraitiene R; Petraitis V; Kelaher AM; Schaufele R; Hope WW; Shea YR; Bacher J; Walsh TJ
    J Clin Microbiol; 2006 Jul; 44(7):2475-80. PubMed ID: 16825367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive pulmonary aspergillosis diagnosed early by polymerase chain reaction assay.
    Kawamura S; Maesaki S; Omagari K; Hashiguchi K; Tomono K; Tashiro T; Kohno S
    Intern Med; 1999 Sep; 38(9):744-6. PubMed ID: 10480308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Threshold of galactomannan antigenemia positivity for early diagnosis of invasive aspergillosis in neutropenic children.
    Dinand V; Anjan M; Oberoi JK; Khanna S; Yadav SP; Wattal C; Sachdeva A
    J Microbiol Immunol Infect; 2016 Feb; 49(1):66-73. PubMed ID: 24582464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients.
    Prattes J; Lackner M; Eigl S; Reischies F; Raggam RB; Koidl C; Flick H; Wurm R; Palfner M; Wölfler A; Neumeister P; Thornton CR; Krause R; Lass-Flörl C; Hoenigl M
    Mycoses; 2015 Aug; 58(8):461-9. PubMed ID: 26103209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.